Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein

Virology

Volumn 335, Issue 1, 2005, Pages 34-45

  Zhi, Yan ^a   Kobinger, Gary P ^a   Jordan, Heather ^a   Suchma, Katie ^b   Weiss, Susan R ^b   Shen, Hao ^b   Schumer, Gregory ^a   Gao, Guangping ^a   Boyer, Julie L ^c   Crystal, Ronald G ^c   Wilson, James M ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d TRL   (United States)

Author keywords

CD8 T cells; Codon optimization; MHC class I epitope; Promoter optimization; Replication defective adenoviral vaccine vectors; SARS CoV

Indexed keywords

ADENOVIRUS VECTOR; CD8 ANTIGEN; CYSTEINYLTYROSYLGLYCYLVALYLSERYLALANYLTHREONYLLYSYLLEUCYLASPARAGINYL ASPARTYLLEUCYLCYSTEINYLPHENYLALANYLSERINE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE ANTIGEN; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; TYROSYLASPARAGINYLTYROSYLLYSYLTYROSYLARGINYLTYROSYLLEUCINE; UNCLASSIFIED DRUG; VALYLASPARAGINYLPHENYLALANYLASPARAGINYLPHENYLALANYLASPARAGINYLGLYCYL LEUCINE; VIRUS ANTIGEN; VIRUS SPIKE PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN DETECTION; ARTICLE; CELLULAR IMMUNITY; CODON; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; EXPERIMENTAL MOUSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SARS CORONAVIRUS; T LYMPHOCYTE; VIRUS IDENTIFICATION; VIRUS REPLICATION;

EID: 20144387276     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.01.050     Document Type: Article

References (49)

1. G.J. Babcock, D.J. Esshaki, W.D. Thomas Jr., and D.M. Ambrosino Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor J. Virol. 78 9 2004 4552 4560
2. C.C. Bergmann, Q. Yao, M. Lin, and S.A. Stohlman The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response J. Gen. Virol. 77 Pt. 2 1996 315 325
3. R.F. Castro, and S. Perlman CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity J. Virol. 69 12 1995 8127 8131
4. A.S. De Groot How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past Vaccine 21 27-30 2003 4095 4104
5. L. Deml, A. Bojak, S. Steck, M. Graf, J. Wild, R. Schirmbeck, H. Wolf, and R. Wagner Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein J. Virol. 75 22 2001 10991 11001
6. J.C. Fitzgerald, G.P. Gao, A. Reyes-Sandoval, G.N. Pavlakis, Z.Q. Xiang, A.P. Wlazlo, W. Giles-Davis, J.M. Wilson, and H.C. Ertl A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag J. Immunol. 170 3 2003 1416 1422
7. R.A. Fouchier, T. Kuiken, M. Schutten, G. van Amerongen, G.J. van Doornum, B.G. van den Hoogen, M. Peiris, W. Lim, K. Stohr, and A.D. Osterhaus Aetiology: Koch's postulates fulfilled for SARS virus Nature 423 6937 2003 240
8. G.P. Gao, R.K. Engdahl, and J.M. Wilson A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus Hum. Gene Ther. 11 1 2000 213 219
9. F. Gao, Y. Li, J.M. Decker, F.W. Peyerl, F. Bibollet-Ruche, C.M. Rodenburg, Y. Chen, D.R. Shaw, S. Allen, R. Musonda, G.M. Shaw, A.J. Zajac, N. Letvin, and B.H. Hahn Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice AIDS Res. Hum. Retroviruses 19 9 2003 817 823
10. G. Gao, X. Zhou, M.R. Alvira, P. Tran, J. Marsh, K. Lynd, W. Xiao, and J.M. Wilson High throughput creation of recombinant adenovirus vectors by direct cloning, green-white selection and I-Sce I-mediated rescue of circular adenovirus plasmids in 293 cells Gene Ther. 10 22 2003 1926 1930
11. M.H. Heemskerk, H.M. Schoemaker, W.J. Spaan, and C.J. Boog Predominance of MHC class II-restricted CD4+ cytotoxic T cells against mouse hepatitis virus A59 Immunology 84 4 1995 521 527
12. H. Hofmann, K. Hattermann, A. Marzi, T. Gramberg, M. Geier, M. Krumbiegel, S. Kuate, K. Uberla, M. Niedrig, and S. Pohlmann S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients J. Virol. 78 12 2004 6134 6142
13. R.J. Hogan, G.P. Gao, T. Rowe, P. Bell, D. Flieder, J. Paragas, G.P. Kobinger, N.A. Wivel, R.G. Crystal, J.D. Boyer, H. Feldmann, T.G. Voss, and J.M. Wilson Resolution of primary SARS-associated coronavirus infection requires Stat1 J. Virol. 78 2004 11416 11421
14. K.V. Holmes SARS coronavirus: a new challenge for prevention and therapy J. Clin. Invest. 111 11 2003 1605 1609
15. Kobinger, G.P., Feldmann, E., Zhi, Y., Schumer, G., Gao, G., Feldmann, F., Jones, S., Wilson, J.M., submitted for publication. Protection mechanism of adenovirus vaccines in murine models of ebola infection and impact of pre-existing immunity to the vaccine carrier.
16. T.G. Ksiazek, D. Erdman, C.S. Goldsmith, S.R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J.A. Comer, W. Lim, P.E. Rollin, S.F. Dowell, A.E. Ling, C.D. Humphrey, W.J. Shieh, J. Guarner, C.D. Paddock, P. Rota, B. Fields, J. DeRisi, J.Y. Yang, N. Cox, J.M. Hughes, J.W. LeDuc, W.J. Bellini, and L.J. Anderson A novel coronavirus associated with severe acute respiratory syndrome N. Engl. J. Med. 348 20 2003 1953 1966
17. T. Kuiken, R.A. Fouchier, M. Schutten, G.F. Rimmelzwaan, G. van Amerongen, D. van Riel, J.D. Laman, T. de Jong, G. van Doornum, W. Lim, A.E. Ling, P.K. Chan, J.S. Tam, M.C. Zambon, R. Gopal, C. Drosten, S. van der Werf, N. Escriou, J.C. Manuguerra, K. Stohr, J.S. Peiris, and A.D. Osterhaus Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome Lancet 362 9380 2003 263 270
18. W. Li, M.J. Moore, N. Vasilieva, J. Sui, S.K. Wong, M.A. Berne, M. Somasundaran, J.L. Sullivan, K. Luzuriaga, T.C. Greenough, H. Choe, and M. Farzan Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 6965 2003 450 454
19. R.R. MacGregor, J.D. Boyer, K.E. Ugen, K.E. Lacy, S.J. Gluckman, M.L. Bagarazzi, M.A. Chattergoon, Y. Baine, T.J. Higgins, R.B. Ciccarelli, L.R. Coney, R.S. Ginsberg, and D.B. Weiner First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response J. Infect. Dis. 178 1 1998 92 100
20. M.A. Marra, S.J. Jones, C.R. Astell, R.A. Holt, A. Brooks-Wilson, Y.S. Butterfield, J. Khattra, J.K. Asano, S.A. Barber, S.Y. Chan, A. Cloutier, S.M. Coughlin, D. Freeman, N. Girn, O.L. Griffith, S.R. Leach, M. Mayo, H. McDonald, S.B. Montgomery, P.K. Pandoh, A.S. Petrescu, A.G. Robertson, J.E. Schein, A. Siddiqui, D.E. Smailus, J.M. Stott, G.S. Yang, F. Plummer, A. Andonov, H. Artsob, N. Bastien, K. Bernard, T.F. Booth, D. Bowness, M. Czub, M. Drebot, L. Fernando, R. Flick, M. Garbutt, M. Gray, A. Grolla, S. Jones, H. Feldmann, A. Meyers, A. Kabani, Y. Li, S. Normand, U. Stroher, G.A. Tipples, S. Tyler, R. Vogrig, D. Ward, B. Watson, R.C. Brunham, M. Krajden, M. Petric, D.M. Skowronski, C. Upton, and R.L. Roper The Genome sequence of the SARS-associated coronavirus Science 300 5624 2003 1399 1404
21. B.E. Martina, B.L. Haagmans, T. Kuiken, R.A. Fouchier, G.F. Rimmelzwaan, G. Van Amerongen, J.S. Peiris, W. Lim, and A.D. Osterhaus Virology: SARS virus infection of cats and ferrets Nature 425 6961 2003 915
22. J.M. Nicholls, L.L. Poon, K.C. Lee, W.F. Ng, S.T. Lai, C.Y. Leung, C.M. Chu, P.K. Hui, K.L. Mak, W. Lim, K.W. Yan, K.H. Chan, N.C. Tsang, Y. Guan, K.Y. Yuen, and J.S. Peiris Lung pathology of fatal severe acute respiratory syndrome Lancet 361 9371 2003 1773 1778
23. H. Niwa, K. Yamamura, and J. Miyazaki Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 108 2 1991 193 199
24. S.E. Parker, T.M. Gallagher, and M.J. Buchmeier Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus Virology 173 2 1989 664 673
25. A.R. Pinto, J.C. Fitzgerald, W. Giles-Davis, G.P. Gao, J.M. Wilson, and H.C. Ertl Induction of CD8+T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers J. Immunol. 171 12 2003 6774 6779
26. A.R. Pinto, J.C. Fitzgerald, G.P. Gao, J.M. Wilson, and H.C. Ertl Induction of CD8+T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector Vaccine 22 5-6 2004 697 703
27. H. Rammensee, J. Bachmann, N.P. Emmerich, O.A. Bachor, and S. Stevanovic SYFPEITHI: database for MHC ligands and peptide motifs Immunogenetics 50 3-4 1999 213 219
28. A. Reyes-Sandoval, J.C. Fitzgerald, R.L. Grant, S. Roy, Z.Q. Xiang, Y. Li, G.P. Gao, J.M. Wilson, and H.C.J. Ertl HIV-1 specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes J. Virol. 78 14 2004 7392 7399
29. P.A. Rota, M.S. Oberste, S.S. Monroe, W.A. Nix, R. Campagnoli, J.P. Icenogle, S. Penaranda, B. Bankamp, K. Maher, M.H. Chen, S. Tong, A. Tamin, L. Lowe, M. Frace, J.L. DeRisi, Q. Chen, D. Wang, D.D. Erdman, T.C. Peret, C. Burns, T.G. Ksiazek, P.E. Rollin, A. Sanchez, S. Liffick, B. Holloway, J. Limor, K. McCaustland, M. Olsen-Rasmussen, R. Fouchier, S. Gunther, A.D. Osterhaus, C. Drosten, M.A. Pallansch, L.J. Anderson, and W.J. Bellini Characterization of a novel coronavirus associated with severe acute respiratory syndrome Science 300 5624 2003 1394 1399
30. S. Roy, G.P. Gao, Y. Lu, X. Zhou, M. Lock, R. Calcedo, and J.M. Wilson Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors Hum. Gene Ther. 15 5 2004 519 530
31. J.W. Shiver, T.M. Fu, L. Chen, D.R. Casimiro, M.E. Davies, R.K. Evans, Z.Q. Zhang, A.J. Simon, W.L. Trigona, S.A. Dubey, L. Huang, V.A. Harris, R.S. Long, X. Liang, L. Handt, W.A. Schleif, L. Zhu, D.C. Freed, N.V. Persaud, L. Guan, K.S. Punt, A. Tang, M. Chen, K.A. Wilson, K.B. Collins, G.J. Heidecker, V.R. Fernandez, H.C. Perry, J.G. Joyce, K.M. Grimm, J.C. Cook, P.M. Keller, D.S. Kresock, H. Mach, R.D. Troutman, L.A. Isopi, D.M. Williams, Z. Xu, K.E. Bohannon, D.B. Volkin, D.C. Montefiori, A. Miura, G.R. Krivulka, M.A. Lifton, M.J. Kuroda, J.E. Schmitz, N.L. Letvin, M.J. Caulfield, A.J. Bett, R. Youil, D.C. Kaslow, and E.A. Emini Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature 415 6869 2002 331 335
32. G. Simmons, J.D. Reeves, A.J. Rennekamp, S.M. Amberg, A.J. Piefer, and P. Bates Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry Proc. Natl. Acad. Sci. U. S. A. 101 12 2004 4240 4245
33. E.J. Snijder, P.J. Bredenbeek, J.C. Dobbe, V. Thiel, J. Ziebuhr, L.L. Poon, Y. Guan, M. Rozanov, W.J. Spaan, and A.E. Gorbalenya Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage J. Mol. Biol. 331 5 2003 991 1004
34. S.A. Stohlman, C.C. Bergmann, M.T. Lin, D.J. Cua, and D.R. Hinton CTL effector function within the central nervous system requires CD4+T cells J. Immunol. 160 6 1998 2896 2904
35. K. Subbarao, J. McAuliffe, L. Vogel, G. Fahle, S. Fischer, K. Tatti, M. Packard, W.J. Shieh, S. Zaki, and B. Murphy Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice J. Virol. 78 7 2004 3572 3577
36. N.J. Sullivan, A. Sanchez, P.E. Rollin, Z.Y. Yang, and G.J. Nabel Development of a preventive vaccine for Ebola virus infection in primates Nature 408 6812 2000 605 609
37. M.A. Sussman, R.A. Shubin, S. Kyuwa, and S.A. Stohlman T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system J. Virol. 63 7 1989 3051 3056
38. F.W. van Ginkel, J.R. McGhee, C. Liu, J.W. Simecka, M. Yamamoto, R.A. Frizzell, E.J. Sorscher, H. Kiyono, and D.W. Pascual Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene J. Immunol. 159 2 1997 685 693
39. R. Wang, J. Epstein, F.M. Baraceros, E.J. Gorak, Y. Charoenvit, D.J. Carucci, R.C. Hedstrom, N. Rahardjo, T. Gay, P. Hobart, R. Stout, T.R. Jones, T.L. Richie, S.E. Parker, D.L. Doolan, J. Norman, and S.L. Hoffman Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine Proc. Natl. Acad. Sci. U. S. A. 98 19 2001 10817 10822
40. Y.D. Wang, W.Y. Sin, G.B. Xu, H.H. Yang, T.Y. Wong, X.W. Pang, X.Y. He, H.G. Zhang, J.N. Ng, C.S. Cheng, J. Yu, L. Meng, R.F. Yang, S.T. Lai, Z.H. Guo, Y. Xie, and W.F. Chen T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS J. Virol. 78 11 2004 5612 5618
41. J.S. Williamson, and S.A. Stohlman Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells J. Virol. 64 9 1990 4589 4592
42. S.K. Wong, W. Li, M.J. Moore, H. Choe, and M. Farzan A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2 J. Biol. Chem. 279 5 2004 3197 3201
43. Z.Q. Xiang, Y. Yang, J.M. Wilson, and H.C. Ertl A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier Virology 219 1 1996 220 227
44. Z. Xiang, G. Gao, A. Reyes-Sandoval, C.J. Cohen, Y. Li, J.M. Bergelson, J.M. Wilson, and H.C. Ertl Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product J. Virol. 76 6 2002 2667 2675
45. Z. Xiang, Y. Li, G. Gao, J.M. Wilson, and H.C. Ertl Mucosally delivered E1-deleted adenoviral vaccine carriers induce transgene product-specific antibody responses in neonatal mice J. Immunol. 171 8 2003 4287 4293
46. Z.Q. Xiang, G.P. Gao, Y. Li, J.M. Wilson, and H.C. Ertl T helper cell-independent antibody responses to the transgene product of an e1-deleted adenoviral vaccine require NK1.1 T cells Virology 305 2 2003 397 405
47. Z.Q. Xiang, G.P. Gao, A. Reyes-Sandoval, Y. Li, J.M. Wilson, and H.C. Ertl Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier J. Virol. 77 20 2003 10780 10789
48. S. Xue, and S. Perlman Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus Virology 238 1 1997 68 78
49. Y. Yang, S.E. Haecker, Q. Su, and J.M. Wilson Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle Hum. Mol. Genet. 5 11 1996 1703 1712